NCT07327021 2026-01-08
NOGA
Tel-Aviv Sourasky Medical Center
Phase 2 Recruiting
Clinical Trials
7 trialsNCT06817525 2025-12-05
Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC
Henan Cancer Hospital
Phase 2 Recruiting
NCT07256964 2025-12-02
Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT06819319 2025-06-23
SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT05475678 2025-01-23
Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
Henan Cancer Hospital
Phase 2 Recruiting
NCT04664972 2024-09-20
Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC
Henan Cancer Hospital
Phase 2 Completed
NCT03756298 2023-11-09
Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Center, Korea
Phase 2 Active not recruiting